期刊文献+

系统性硬化病治疗进展 被引量:2

原文传递
导出
摘要 系统性硬化病(systemic sclerosis,SSc)是一种全身性自身免疾病,以皮肤纤维化及内脏受累(肺、消化系统、肾、心脏等)为特征.SSc的发病机制复杂,目前尚未阐明.因此SSc一直缺乏有效的治疗方法.现就SSc的免疫调节治疗、血管病治疗、抗纤维化治疗综述如下.
作者 张莉 李梦涛
机构地区 中国医学科学院
出处 《中华内科杂志》 CAS CSCD 北大核心 2011年第8期707-709,共3页 Chinese Journal of Internal Medicine
基金 欧洲抗风湿病联盟硬皮病试验研究项目 首都医学发展科研基金重点支持项目(2009-2003) 中华医学会临床医学科研专项资金项目(08010270105) 北京协和医院青年科研基金(I604900)
  • 相关文献

参考文献25

  • 1Varga J, Denton CP. Systemic sclerosis and the scleroderma- spectrum disorders//Gary SF, Ralph CB. Kelley' s textbook of rheumatology. 8 th ed. Philadelphia : Saunders, 2008 : 131 ! - 1351.
  • 2Kowal-Bielecka O, Landew6 R, Avouac J, et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis,2009,68:620-628.
  • 3Yanthuyne M, Blockmans D, Westhovens R, et al. A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis. Clin Exp Rheumatol,2007 ,25 :287-292.
  • 4Derk CT, Grace E, Shenin M, et al. A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis. Rheumatology (Oxford) ,2009,48:1595-1599.
  • 5Gerbino AJ, Goss CH, Molitor JA. Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease. Chest ,2008,133:455-460.
  • 6Nihtyanova SI, Brough GM, Black CM, et al. Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis. Rheumatology (Oxford) ,2007,46:442-445.
  • 7Morton SJ, Powell RJ. Cyelosporin and tacrolimus: their use in a routine clinical setting for scleroderma. Rheumatology ( Oxford), 2000,39 : 865 -869.
  • 8Kroft EB, Groeneveld TJ, Seyger MM, et al. Efficacy of topical tacrolimus 0.1% in active plaque morphea : randomized, double- bhnd, emollient-controlled pilot study. Am J Clin Dermatol,2009, 10:181-187.
  • 9Farge D, Passweg J, van Laar JM, et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis,2004,63:974-981.
  • 10Oyama Y, Barr WG, Statkute L, et al. Autologous non- myeloablative hematopoletic stem cell transplantation in patients with systemic sclerosis. Bone Marrow Transplant, 2007,40 : 549-555.

二级参考文献2

  • 1P. R. J. Ames,C. Tommasino,G. Fossati,G. Scenna,V. Brancaccio,F. Ferrara. Limited effect of rituximab on thrombocytopaenia and anticardiolipin antibodies in a patient with primary antiphospholipid syndrome[J] 2007,Annals of Hematology(3):227~228
  • 2R. Trappe,A. Loew,P. Thuss-Patience,B. D?rken,H. Riess. Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab—monitoring of antiphospholipid and anti-GP antibodies: a case report[J] 2006,Annals of Hematology(2):134~135

共引文献1

同被引文献27

  • 1史坚.浅析系统性硬皮病的胸部x线表现[J].求医问药(下半月),2013(9):168-169. 被引量:1
  • 2李莉,唐福林.硬皮病肾危象四例[J].中华皮肤科杂志,1998,31(1):124-134.
  • 3赵久良,冯云路.内科住院医师手册(第二版)[M].北京:中国协和医科大学出版社,2015:96-97.
  • 4维吉尼亚·萨提亚.萨提亚家庭治疗模式[M].北京:世界图书出版公司.2015:93-143.
  • 5Kocheril SV, Appleton BE, Somers EC, et al.. Compa- rision of disease progression and mortality of connective tissue disease-related interstitial lung disease and idio- pathic interstitial neumonia [J]. Arthritis Rheum, 2005,53(4) 549-557.
  • 6Au K, Khanna D, Clements PJ, et al.. Current con- cepts in disease-modifying therapy for systemic sclero- sis-associated interstitial lung disease lessons from clinical trials[J]. Curr Rheumato Rep, 2009,11 (2) : 111-119.
  • 7White B. Interstitial lung disease in scleroderma[J]. Rheum Dis Clin North Am ,2003,29(2) ..371-390.
  • 8Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002 [J]. Ann Rheum Dis, 2007,66(7) ..940-944.
  • 9杜彭,魏蔚,巩路.结缔组织病并发肺动脉高压的临床特点研究[J].天津医科大学学报,2010,16(1):72-74. 被引量:7
  • 10王迁,赵久良,李梦涛,徐东,侯勇,胡朝军,张奉春,赵岩,曾小峰.抗膜突蛋白抗体与系统性硬化病相关肺间质病变的临床相关性研究[J].中华风湿病学杂志,2010,14(6):364-367. 被引量:4

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部